000 01195 a2200277 4500
005 20250513222357.0
264 0 _c20010301
008 200103s 0 0 eng d
022 _a1079-2082
024 7 _a10.1093/ajhp/57.19.1797
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBurnakis, T G
245 0 0 _aTherapeutic interchange of low-molecular-weight heparins.
_h[electronic resource]
260 _bAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
_cOct 2000
300 _a1797-8; author reply 1800-2 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAnticoagulants
_xeconomics
650 0 4 _aCost Savings
650 0 4 _aDalteparin
_xeconomics
650 0 4 _aEnoxaparin
_xeconomics
650 0 4 _aHumans
650 0 4 _aTherapeutic Equivalency
650 0 4 _aVenous Thrombosis
_xprevention & control
773 0 _tAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
_gvol. 57
_gno. 19
_gp. 1797-8; author reply 1800-2
856 4 0 _uhttps://doi.org/10.1093/ajhp/57.19.1797
_zAvailable from publisher's website
999 _c10975138
_d10975138